{"rows":[{"id":383,"title":"Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.","authors":"Griffiths RR, Jesse R, Richards WA, Johnson MW, Sepeda ND, Bossis AP, Ross S","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2025-12-01","publication_year":2025,"doi":"10.1089/psymed.2023.0044","pubmed_id":"41869007","openalex_id":"https://openalex.org/W4410448036","source_url":"https://pubmed.ncbi.nlm.nih.gov/41869007/","substance_tags":"psilocybin","topic_tags":"Wellbeing,Spirituality,Mystical Experience,Clinical Trial,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:54","bibtex":null,"source_record_id":"PMID:41869007","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41869007/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41869007","source_url":"https://pubmed.ncbi.nlm.nih.gov/41869007/","doi":"10.1089/psymed.2023.0044","pmid":"41869007","publication_date":"2025-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":793,"title":"A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.","authors":"Yaden DB, Graziosi M, Owen AM, Agin-Liebes G, Aaronson ST, Allen KE, Barrett FS, Bogenschutz MP, Carhart-Harris R, Ching THW, Cosimano MP, Danforth A, Davis AK, Garcia-Romeu A, Griffiths R, Grob CS, Gründer G, Gukasyan N, Heinzerling KG, Hendricks PS, Holze F, Horton DM, Johnson MW, Kelmendi B, Knatz Peck S, Koslowski M, Liechti ME, Mertens LJ, Moreno FA, Nayak SM, Nicholas CR, Preller KH, Rieser NM, Ross S, Sergi K, Sloshower J, Smigielski L, Stenbæk DS, Vollenweider FX, Weiss B, Wolff M, Yaden ME","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2025-03-01","publication_year":2025,"doi":"10.1089/psymed.2024.0019","pubmed_id":"40351554","openalex_id":"https://openalex.org/W4406633420","source_url":"https://pubmed.ncbi.nlm.nih.gov/40351554/","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Consciousness,Wellbeing,Review Article,Safety,Adverse Events,Contraindications","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:01","bibtex":null,"source_record_id":"PMID:40351554","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40351554/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40351554","source_url":"https://pubmed.ncbi.nlm.nih.gov/40351554/","doi":"10.1089/psymed.2024.0019","pmid":"40351554","publication_date":"2025-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":641,"title":"Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study.","authors":"Nayak SM, White SH, Hilbert SN, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB","journal":"Journal of psychoactive drugs","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1080/02791072.2024.2346130","pubmed_id":"38715376","openalex_id":"https://openalex.org/W4396728212","source_url":"https://pubmed.ncbi.nlm.nih.gov/38715376/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:58","bibtex":null,"source_record_id":"PMID:38715376","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38715376/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38715376","source_url":"https://pubmed.ncbi.nlm.nih.gov/38715376/","doi":"10.1080/02791072.2024.2346130","pmid":"38715376","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":968,"title":"Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer.","authors":"Petridis PD, Grinband J, Agin-Liebes G, Kinslow CJ, Zeifman RJ, Bogenschutz MP, Griffiths RR, Ross S","journal":"Nature. Mental health","publication_date":"2024-11-01","publication_year":2024,"doi":"10.1038/s44220-024-00331-0","pubmed_id":"41969367","openalex_id":"https://openalex.org/W4403196849","source_url":"https://pubmed.ncbi.nlm.nih.gov/41969367/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Clinical Trial,Cancer Patients","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:06","bibtex":null,"source_record_id":"PMID:41969367","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41969367/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41969367","source_url":"https://pubmed.ncbi.nlm.nih.gov/41969367/","doi":"10.1038/s44220-024-00331-0","pmid":"41969367","publication_date":"2024-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4596,"title":"Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin Therapy","authors":"Alan K. Davis, Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, Natalie Gukasyan, Sandeep M. Nayak, Frederick S. Barrett, Roland R. Griffiths","journal":"Drug and Alcohol Dependence","publication_date":"2024-07-01","publication_year":2024,"doi":"10.1016/j.drugalcdep.2023.110609","pubmed_id":null,"openalex_id":"https://openalex.org/W4400575216","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110609","substance_tags":"psilocybin","topic_tags":"Anxiety","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:28","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2023.110609","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2023.110609","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110609","doi":"10.1016/j.drugalcdep.2023.110609","pmid":"","publication_date":"2024-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4592,"title":"Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or Psilocybin","authors":"Rafael Lancelotta, Christopher Timmerman, Ana María Ortiz Bernal, Sandeep M. Nayak, Nathan D. Sepeda, Aki Nikolaidis, Roland R. Griffiths, Alan K. Davis","journal":"Drug and Alcohol Dependence","publication_date":"2024-07-01","publication_year":2024,"doi":"10.1016/j.drugalcdep.2023.110861","pubmed_id":null,"openalex_id":"https://openalex.org/W4400574241","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110861","substance_tags":"psilocybin","topic_tags":"Toxicity","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:28","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2023.110861","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2023.110861","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110861","doi":"10.1016/j.drugalcdep.2023.110861","pmid":"","publication_date":"2024-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1105,"title":"Impact of Psilocybin on Peripheral Cytokine Production.","authors":"DiRenzo D, Barrett FS, Perin J, Darrah E, Christopher-Stine L, Griffiths RR","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2024-06-01","publication_year":2024,"doi":"10.1089/psymed.2023.0039","pubmed_id":"40051582","openalex_id":"https://openalex.org/W4392242985","source_url":"https://pubmed.ncbi.nlm.nih.gov/40051582/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Clinical Trial,Randomized Controlled Trial,Inflammation,Immune Function","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:08","bibtex":null,"source_record_id":"PMID:40051582","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40051582/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40051582","source_url":"https://pubmed.ncbi.nlm.nih.gov/40051582/","doi":"10.1089/psymed.2023.0039","pmid":"40051582","publication_date":"2024-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1199,"title":"The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.","authors":"Levin AW, Lancelotta R, Sepeda ND, Gukasyan N, Nayak S, Wagener TL, Barrett FS, Griffiths RR, Davis AK","journal":"PloS one","publication_date":"2024-01-01","publication_year":2024,"doi":"10.1371/journal.pone.0300501","pubmed_id":"38483940","openalex_id":"https://openalex.org/W4392797453","source_url":"https://pubmed.ncbi.nlm.nih.gov/38483940/","substance_tags":"psilocybin","topic_tags":"Depression,Mystical Experience,Clinical Trial","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:10","bibtex":null,"source_record_id":"PMID:38483940","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38483940/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38483940","source_url":"https://pubmed.ncbi.nlm.nih.gov/38483940/","doi":"10.1371/journal.pone.0300501","pmid":"38483940","publication_date":"2024-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1045,"title":"Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences.","authors":"Davis AK, Timmermann C, Ortiz Bernal AM, Lancelotta R, Nayak S, Sepeda ND, Nikolaidis A, Griffiths RR","journal":"Journal of psychoactive drugs","publication_date":"2024-01-01","publication_year":2024,"doi":"10.1080/02791072.2023.2232379","pubmed_id":"37449499","openalex_id":"https://openalex.org/W4384339800","source_url":"https://pubmed.ncbi.nlm.nih.gov/37449499/","substance_tags":"psilocybin","topic_tags":"Mystical Experience,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:07","bibtex":null,"source_record_id":"PMID:37449499","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37449499/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37449499","source_url":"https://pubmed.ncbi.nlm.nih.gov/37449499/","doi":"10.1080/02791072.2023.2232379","pmid":"37449499","publication_date":"2024-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1315,"title":"Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers.","authors":"Mathai DS, Hilbert S, Sepeda ND, Strickland JC, Griffiths RR, Garcia-Romeu A","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2023-12-01","publication_year":2023,"doi":"10.1089/psymed.2023.0035","pubmed_id":"38152462","openalex_id":"https://openalex.org/W4386285211","source_url":"https://pubmed.ncbi.nlm.nih.gov/38152462/","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Consciousness,Wellbeing,Spirituality,Healthy Volunteers,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:11","bibtex":null,"source_record_id":"PMID:38152462","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38152462/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38152462","source_url":"https://pubmed.ncbi.nlm.nih.gov/38152462/","doi":"10.1089/psymed.2023.0035","pmid":"38152462","publication_date":"2023-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1379,"title":"Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.","authors":"Raison CL, Sanacora G, Woolley J, Heinzerling K, Dunlop BW, Brown RT, Kakar R, Hassman M, Trivedi RP, Robison R, Gukasyan N, Nayak SM, Hu X, O'Donnell KC, Kelmendi B, Sloshower J, Penn AD, Bradley E, Kelly DF, Mletzko T, Nicholas CR, Hutson PR, Tarpley G, Utzinger M, Lenoch K, Warchol K, Gapasin T, Davis MC, Nelson-Douthit C, Wilson S, Brown C, Linton W, Ross S, Griffiths RR","journal":"JAMA","publication_date":"2023-09-05","publication_year":2023,"doi":"10.1001/jama.2023.14530","pubmed_id":"37651119","openalex_id":"https://openalex.org/W4386305655","source_url":"https://pubmed.ncbi.nlm.nih.gov/37651119/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Clinical Trial,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:12","bibtex":null,"source_record_id":"PMID:37651119","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37651119/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37651119","source_url":"https://pubmed.ncbi.nlm.nih.gov/37651119/","doi":"10.1001/jama.2023.14530","pmid":"37651119","publication_date":"2023-09-05","importer_version":"2.1.3","text_redistributed":false}},{"id":1390,"title":"Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.","authors":"Simonsson O, Carlbring P, Carhart-Harris R, Davis AK, Nutt DJ, Griffiths RR, Erritzoe D, Goldberg SB","journal":"Psychiatry research","publication_date":"2023-09-01","publication_year":2023,"doi":"10.1016/j.psychres.2023.115349","pubmed_id":"37523886","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/37523886/","substance_tags":"psilocybin","topic_tags":"Depression,Meta-Analysis,Systematic Review,Review Article,Safety","study_type":"Meta-Analysis","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:13","bibtex":null,"source_record_id":"PMID:37523886","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37523886/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37523886","source_url":"https://pubmed.ncbi.nlm.nih.gov/37523886/","doi":"10.1016/j.psychres.2023.115349","pmid":"37523886","publication_date":"2023-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1447,"title":"Corrigendum to 'Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity': Neuroimage 2022 Oct 15;260:119434.","authors":"Gaddis A, Lidstone DE, Nebel MB, Griffiths RR, Mostofsky SH, Mejia AF, Barrett FS","journal":"NeuroImage","publication_date":"2023-07-01","publication_year":2023,"doi":"10.1016/j.neuroimage.2023.120130","pubmed_id":"37148779","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/37148779/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:15","bibtex":null,"source_record_id":"PMID:37148779","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37148779","source_url":"https://pubmed.ncbi.nlm.nih.gov/37148779/","doi":"10.1016/j.neuroimage.2023.120130","pmid":"37148779","publication_date":"2023-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1443,"title":"Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.","authors":"Gukasyan N, Griffiths RR, Yaden DB, Antoine DG, Nayak SM","journal":"Journal of psychopharmacology (Oxford, England)","publication_date":"2023-07-01","publication_year":2023,"doi":"10.1177/02698811231179910","pubmed_id":"37291890","openalex_id":"https://openalex.org/W4379967727","source_url":"https://pubmed.ncbi.nlm.nih.gov/37291890/","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Observational Study,Drug Interactions","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:14","bibtex":null,"source_record_id":"PMID:37291890","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37291890/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37291890","source_url":"https://pubmed.ncbi.nlm.nih.gov/37291890/","doi":"10.1177/02698811231179910","pmid":"37291890","publication_date":"2023-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3793,"title":"Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study","authors":"Nayak SM, White S, Hilbert S, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB.","journal":"PsyArXiv","publication_date":"2023-06-09","publication_year":2023,"doi":"10.31234/osf.io/auycp","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.31234/osf.io/auycp","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PsyArXiv","publication_status":"preprint","date_added":"2026-07-01 11:10:22","last_checked":"2026-08-09 08:15:27","bibtex":null,"source_record_id":"DOI:10.31234/osf.io/auycp","abstract_available":true,"abstract_source":"PsyArXiv","abstract_source_url":"https://doi.org/10.31234/osf.io/auycp","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/auycp","source_url":"https://doi.org/10.31234/osf.io/auycp","doi":"10.31234/osf.io/auycp","pmid":"","publication_date":"2023-06-09","importer_version":"2.1.3","text_redistributed":false}},{"id":3359,"title":"Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study","authors":"Nayak SM, White SH, Hilbert S, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB.","journal":"PsyArXiv","publication_date":"2023-06-09","publication_year":2023,"doi":"10.31234/osf.io/auycp_v1","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.31234/osf.io/auycp_v1","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PsyArXiv","publication_status":"preprint","date_added":"2026-07-01 11:03:51","last_checked":"2026-08-09 08:15:27","bibtex":null,"source_record_id":"DOI:10.31234/osf.io/auycp_v1","abstract_available":true,"abstract_source":"PsyArXiv","abstract_source_url":"https://doi.org/10.31234/osf.io/auycp_v1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/auycp_v1","source_url":"https://doi.org/10.31234/osf.io/auycp_v1","doi":"10.31234/osf.io/auycp_v1","pmid":"","publication_date":"2023-06-09","importer_version":"2.1.3","text_redistributed":false}},{"id":3358,"title":"Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study","authors":"Sandeep M Nayak, Sydney White, Samantha Hilbert, Matthew X Lowe, Heather Jackson, Roland R. Griffiths, Albert Garcia-Romeu, David Bryce Yaden","journal":"PsyArXiv","publication_date":"2023-06-09","publication_year":2023,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://osf.io/preprints/psyarxiv/auycp_v1","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PsyArXiv","publication_status":"preprint","date_added":"2026-07-01 11:03:51","last_checked":"2026-08-09 08:20:21","bibtex":null,"source_record_id":"https://osf.io/preprints/psyarxiv/auycp_v1","abstract_available":true,"abstract_source":"PsyArXiv","abstract_source_url":"https://osf.io/preprints/psyarxiv/auycp_v1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/auycp_v1","source_url":"https://osf.io/preprints/psyarxiv/auycp_v1","doi":"","pmid":"","publication_date":"2023-06-09","importer_version":"2.1.3","text_redistributed":false}},{"id":1372,"title":"Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.","authors":"Nayak SM, Jackson H, Sepeda ND, Mathai DS, So S, Yaffe A, Zaki H, Brasher TJ, Lowe MX, Jolly DRP, Barrett FS, Griffiths RR, Strickland JC, Johnson MW, Jackson H, Garcia-Romeu A","journal":"Frontiers in psychiatry","publication_date":"2023-01-01","publication_year":2023,"doi":"10.3389/fpsyt.2023.1199642","pubmed_id":"37795509","openalex_id":"https://openalex.org/W4386861633","source_url":"https://pubmed.ncbi.nlm.nih.gov/37795509/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Wellbeing,Emotional Processing,Spirituality,Mystical Experience,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:12","bibtex":null,"source_record_id":"PMID:37795509","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37795509/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37795509","source_url":"https://pubmed.ncbi.nlm.nih.gov/37795509/","doi":"10.3389/fpsyt.2023.1199642","pmid":"37795509","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1627,"title":"Psychedelic-Assisted Therapy for People with Eating Disorders.","authors":"Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS","journal":"Current psychiatry reports","publication_date":"2022-12-01","publication_year":2022,"doi":"10.1007/s11920-022-01394-5","pubmed_id":"36374357","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/36374357/","substance_tags":"psilocybin","topic_tags":"Eating Disorders,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:18","bibtex":null,"source_record_id":"PMID:36374357","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36374357/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36374357","source_url":"https://pubmed.ncbi.nlm.nih.gov/36374357/","doi":"10.1007/s11920-022-01394-5","pmid":"36374357","publication_date":"2022-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1650,"title":"Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.","authors":"Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ","journal":"Neuropharmacology","publication_date":"2022-11-01","publication_year":2022,"doi":"10.1016/j.neuropharm.2022.109220","pubmed_id":"35987353","openalex_id":"https://openalex.org/W4292136326","source_url":"https://pubmed.ncbi.nlm.nih.gov/35987353/","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Consciousness,Spirituality,Safety,Abuse Liability","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:18","bibtex":null,"source_record_id":"PMID:35987353","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35987353/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35987353","source_url":"https://pubmed.ncbi.nlm.nih.gov/35987353/","doi":"10.1016/j.neuropharm.2022.109220","pmid":"35987353","publication_date":"2022-11-01","importer_version":"2.1.3","text_redistributed":false}}],"total":84,"page":1,"per_page":20,"pages":5,"resource":"papers","filters":{"q":null,"author":"Roland R. Griffiths","substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newest","page":1,"per_page":"20"}}